97 related articles for article (PubMed ID: 22725988)
21. IGF-IR: a new prognostic biomarker for human glioblastoma.
Maris C; D'Haene N; Trépant AL; Le Mercier M; Sauvage S; Allard J; Rorive S; Demetter P; Decaestecker C; Salmon I
Br J Cancer; 2015 Sep; 113(5):729-37. PubMed ID: 26291053
[TBL] [Abstract][Full Text] [Related]
22. Predictive Factors Determining the Overall Outcome of Primary Spinal Glioblastoma Multiforme: An Integrative Survival Analysis.
Konar SK; Maiti TK; Bir SC; Kalakoti P; Bollam P; Nanda A
World Neurosurg; 2016 Feb; 86():341-8.e1-3. PubMed ID: 26348566
[TBL] [Abstract][Full Text] [Related]
23. [Clinical prognostic factors of adult supratentorial glioblastoma].
Jiang HH; Ren XH; Cui Y; Li MX; Yang KY; Lei YF; Lin S
Zhonghua Wai Ke Za Zhi; 2019 May; 57(5):377-382. PubMed ID: 31091594
[No Abstract] [Full Text] [Related]
24. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.
McGirt MJ; Chaichana KL; Attenello FJ; Weingart JD; Than K; Burger PC; Olivi A; Brem H; Quinoñes-Hinojosa A
Neurosurgery; 2008 Oct; 63(4):700-7; author reply 707-8. PubMed ID: 18981880
[TBL] [Abstract][Full Text] [Related]
25. Primary human glioblastomas - prognostic value of clinical and histopathological parameters.
Habberstad AH; Lind-Landström T; Sundstrøm S; Torp SH
Clin Neuropathol; 2012; 31(5):361-8. PubMed ID: 22939176
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and pathogenesis of cerebellar glioblastoma.
Takahashi Y; Makino K; Nakamura H; Hide T; Yano S; Kamada H; Kuratsu J
Mol Med Rep; 2014 Nov; 10(5):2383-8. PubMed ID: 25199771
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Factors in Glioblastoma: Is There a Role for Epilepsy?
Dobran M; Nasi D; Chiriatti S; Gladi M; Somma LD; Iacoangeli M; Scerrati M
Neurol Med Chir (Tokyo); 2018 Mar; 58(3):110-115. PubMed ID: 29343677
[TBL] [Abstract][Full Text] [Related]
28. Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma.
Cho HJ; Zhao J; Jung SW; Ladewig E; Kong DS; Suh YL; Lee Y; Kim D; Ahn SH; Bordyuh M; Kang HJ; Sa JK; Seo YJ; Kim ST; Lim DH; Dho YS; Lee JI; Seol HJ; Choi JW; Park WY; Park CK; Rabadan R; Nam DH
Neuro Oncol; 2019 Jan; 21(1):47-58. PubMed ID: 30085274
[TBL] [Abstract][Full Text] [Related]
29. Quality-adjusted survival after tumor resection and/or radiation therapy for elderly patients with glioblastoma multiforme.
Muacevic A; Kreth FW
J Neurol; 2003 May; 250(5):561-8. PubMed ID: 12736735
[TBL] [Abstract][Full Text] [Related]
30. Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-Oncology.
Jung TY; Lee JY; Kim DS; Park HJ; Kim CY; Ra YS; Lee MJ; Kim SH; Baek HJ; Kim IH; Park KD; Kim SK
J Neurooncol; 2015 Jan; 121(2):413-9. PubMed ID: 25366367
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors and treatment options for paediatric ependymomas.
Vaidya K; Smee R; Williams JR
J Clin Neurosci; 2012 Sep; 19(9):1228-35. PubMed ID: 22840355
[TBL] [Abstract][Full Text] [Related]
32. Expression of EGFR in Paired New and Recurrent Glioblastomas.
Cioca A; Olteanu EG; Gisca MD; Morosanu CO; Marin I; Florian IS
Asian Pac J Cancer Prev; 2016; 17(9):4205-4208. PubMed ID: 27797218
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of annexin VII expression in glioblastomas multiforme in humans.
Hung KS; Howng SL
J Neurosurg; 2003 Nov; 99(5):886-92. PubMed ID: 14609169
[TBL] [Abstract][Full Text] [Related]
34. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging.
Murakami R; Sugahara T; Nakamura H; Hirai T; Kitajima M; Hayashida Y; Baba Y; Oya N; Kuratsu J; Yamashita Y
Radiology; 2007 May; 243(2):493-9. PubMed ID: 17356177
[TBL] [Abstract][Full Text] [Related]
35. Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration.
Ruano Y; Ribalta T; de Lope AR; Campos-Martín Y; Fiaño C; Pérez-Magán E; Hernández-Moneo JL; Mollejo M; Meléndez B
Am J Clin Pathol; 2009 Feb; 131(2):257-63. PubMed ID: 19141386
[TBL] [Abstract][Full Text] [Related]
36. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.
Farrell C; Shi W; Bodman A; Olson JJ
J Neurooncol; 2020 Nov; 150(2):269-359. PubMed ID: 33215345
[TBL] [Abstract][Full Text] [Related]
37. Clinical implications of multiple glioblastomas: An analysis of prognostic factors and survival to distinguish from their single counterparts.
Shieh LT; Guo HR; Chang YK; Lu NM; Ho SY
J Formos Med Assoc; 2020 Mar; 119(3):728-734. PubMed ID: 31515159
[TBL] [Abstract][Full Text] [Related]
38. Comparative Analysis of Survival Outcomes and Prognostic Factors of Supratentorial versus Cerebellar Glioblastoma in the Elderly: Does Location Really Matter?
Chandra A; Lopez-Rivera V; Dono A; Brandel MG; Lewis C; O'Connor KP; Sheth SA; Ballester LY; Aghi MK; Esquenazi Y
World Neurosurg; 2021 Feb; 146():e755-e767. PubMed ID: 33171326
[TBL] [Abstract][Full Text] [Related]
39. Radiological assessment of necrosis in glioblastoma: variability and prognostic value.
Pierallini A; Bonamini M; Pantano P; Palmeggiani F; Raguso M; Osti MF; Anaveri G; Bozzao L
Neuroradiology; 1998 Mar; 40(3):150-3. PubMed ID: 9561517
[TBL] [Abstract][Full Text] [Related]
40. Long-term survival in patients with supratentorial glioblastoma.
Salvati M; Cervoni L; Artico M; Caruso R; Gagliardi FM
J Neurooncol; 1998 Jan; 36(1):61-4. PubMed ID: 9525826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
